Carcinoma, Squamous Cell

"Carcinoma, Squamous Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Descriptor ID	D002294
MeSH Number(s)	C04.557.470.200.400 C04.557.470.700.400
Concept/Terms	Carcinoma, Squamous Cell Carcinoma, Squamous Cell Carcinomas, Squamous Cell Squamous Cell Carcinomas Squamous Cell Carcinoma Carcinoma, Squamous Carcinomas, Squamous Squamous Carcinoma Squamous Carcinomas Carcinoma, Epidermoid Carcinomas, Epidermoid Epidermoid Carcinoma Epidermoid Carcinomas Carcinoma, Planocellular Carcinomas, Planocellular Planocellular Carcinoma Planocellular Carcinomas

Below are MeSH descriptors whose meaning is more general than "Carcinoma, Squamous Cell".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Glandular and Epithelial [C04.557.470]
Carcinoma [C04.557.470.200]
Carcinoma, Squamous Cell [C04.557.470.200.400]
Neoplasms, Squamous Cell [C04.557.470.700]
Carcinoma, Squamous Cell [C04.557.470.700.400]

Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Squamous Cell".

Carcinoma, Squamous Cell
Bowen's Disease

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Carcinoma, Squamous Cell" by people in this website by year, and whether "Carcinoma, Squamous Cell" was a major or minor topic of these publications.

Bar chart showing 208 publications over 29 distinct years, with a maximum of 16 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1997	1	1	2
1998	1	0	1
1999	1	1	2
2001	2	0	2
2002	3	2	5
2003	5	0	5
2004	5	0	5
2005	5	1	6
2006	2	0	2
2007	9	3	12
2008	12	1	13
2009	8	0	8
2010	4	2	6
2011	11	5	16
2012	11	0	11
2013	12	0	12
2014	13	1	14
2015	6	0	6
2016	15	0	15
2017	13	2	15
2018	8	1	9
2019	3	3	6
2020	4	2	6
2021	7	0	7
2022	6	0	6
2023	6	0	6
2024	4	1	5
2025	3	1	4

Below are the most recent publications written about "Carcinoma, Squamous Cell" by people in Profiles.

Oka T, Smith SS, Oliver-Garcia VS, Lee T, Son HG, Mortaja M, Azin M, Garza-Mayers AC, Huang JT, Nazarian RM, Horn TD, Demehri S. Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer. Cell Rep. 2025 May 27; 44(5):115561.

View in: PubMed
Zhu X, Meng X, Mochel MC, Wiliams EA, Dresser K, Tomaszewicz K, Hutchinson L, Bledsoe JR. CYLD-mutated anal squamous cell carcinoma: An uncommon entity associated with cylindroma-like morphology and adverse clinical features. Hum Pathol. 2025 Mar; 157:105765.

View in: PubMed
Zhou P, Yeshoua BJ, Konuthula N, Pan CJ, Ferrandino RM, Holte SE, Rizvi Z, Marchiano EM, Futran ND, Barber BR. Association of Oral Health Determinants With Oral Squamous Cell Carcinoma in Never-Smoking Adults. Head Neck. 2025 Jul; 47(7):2025-2032.

View in: PubMed
Brady JS, Norouzi A, Konuthula N, Lam A, Marchiano E, Futran N, Barber B. Examining the Impact of Race and Sex on the Incidence of Positive Surgical Margins in Oral Cavity Squamous Cell Carcinoma. Head Neck. 2025 May; 47(5):1512-1519.

View in: PubMed
Challapalli A, Stewart G, Shaw H, Davies PJ, Lopez-Baez JC, Ottley EC, Kelly S. Real-world evidence study on the early use of cemiplimab in the UK: REACT-CEMI (Real World evidence of advanced CSCC treatment with cemiplimab). Front Immunol. 2024; 15:1408667.

View in: PubMed
Laus AC, Gomes INF, da Silva ALV, da Silva LS, Milan MB, AparecidaTeixeira S, Martin ACBM, do Nascimento Braga Pereira L, de Carvalho CEB, Crovador CS, de Paula FE, Nascimento FC, de Freitas HT, de Lima Vazquez V, Reis RM, da Silva-Oliveira RJ. Establishment and molecular characterization of HCB-541, a novel and aggressive human cutaneous squamous cell carcinoma cell line. Hum Cell. 2024 Jul; 37(4):1170-1183.

View in: PubMed
Ortiz AE, Ahluwalia J, Anderson RR, Franco W, Brian Jiang SI. Autofluorescence Excitation Imaging of Nonmelanoma Skin Cancer for Margin Assessment Before Mohs Micrographic Surgery: A Pilot Study. Dermatol Surg. 2024 07 01; 50(7):616-619.

View in: PubMed
Cornejo KM, Hutchinson L, O'Donnell P, Meng X, Tomaszewicz K, Shalin SC, Cassarino DS, Chan MP, Quinn TR, Googe PB, Nazarian RM. Molecular Profiling of Syringocystadenocarcinoma Papilliferum Reveals RAS-Activating Mutations. Arch Pathol Lab Med. 2024 Feb 01; 148(2):215-222.

View in: PubMed
Hanna GJ, Dharanesswaran H, Giobbie-Hurder A, Harran JJ, Liao Z, Pai L, Tchekmedyian V, Ruiz ES, Waldman AH, Schmults CD, Riella LV, Lizotte P, Paweletz CP, Chandraker AK, Murakami N, Silk AW. Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma. J Clin Oncol. 2024 Mar 20; 42(9):1021-1030.

View in: PubMed
Massey PR, Wang DM, Murad F, Mulvaney P, Moore K, Okhovat JP, Russell-Goldman E, Lin WM, Piris A, Huilgol SC, Ruiz ES, Schmults CD. Extensive Perineural Invasion vs Nerve Caliber to Assess Cutaneous Squamous Cell Carcinoma Prognosis. JAMA Dermatol. 2023 12 01; 159(12):1332-1338.

View in: PubMed

People

Explore

Similar Concepts

Top Journals